Germany – Diagnostic systems – Rahmenvereinbarung über Reagenzienleasing für die Analytik mittels Schnell-PCR
Description
The subject of the tender is the conclusion of a framework agreement for the leasing of reagents for rapid PCR analysis for a respiratory 4-fold panel. The service includes the provision of reagents, quality controls, calibrators, consumables, small materials and other materials required for the analysis, as well as the provision, use and operation of the analytical equipment required for this, including software, interface/connection services, maintenance, repair, updates, support and other service services. The respiratory 4-fold panel includes the analysis of the respiratory viruses Influenza A, Influenza B, Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV/SARS-CoV-2). The remuneration is made via a uniform price per billable finding.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Medical computer equipment – Rahmenvereinbarung über die Lieferung von Medical-AIO-PC-Technik
Klinikum Chemnitz gGmbH, c/o Klinikum Chemnitz Logistik- u. Wirtschaftsgesellschaft mbHGermanyMedical computer equipmentComputer equipment and suppliesDeadline in 30 daysPublished on Oct 12, 2026
Germany – Pharmaceutical products – Arzneimittel- Rahmenrabattverträge nach §130a Absatz 8 SGB V
Kaufmännische Krankenkasse - KKHGermanyPharmaceutical productsDeadline in 10 daysPublished on Oct 12, 2026
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 779 daysPublished on Oct 12, 2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tiotropiumbromid (ATC-Code nach WHO: R03BB04)
AOK PLUS - Die Gesundheitskasse für Sachsen und ThüringenGermanyPharmaceutical productsDeadline in 810 daysPublished on Oct 12, 2026